|
June 2013
|
June Is National Aphasia Awareness Month
A Common Myth About Stroke Survivors
|

|
One in four stroke survivors experience some form of language impairment
after a stroke. This impairment is called aphasia, a disorder of
communication that damages a person's ability to use and comprehend
language.
|
|
Because stroke survivors with aphasia have difficulty speaking and understanding language, they are often mistaken for having impaired cognitive functions. But aphasia does not affect intelligence.
» Learn about
aphasia’s symptoms, treatment and management.
» Watch
a webinar about aphasia and get aphasia resources.
|

|
How Two Men Learned to Communicate
“Aphasia is not like a cold, and it does not get better in a few weeks….But it does get
better over time!” —Kurt, stroke survivor
|
Kurt
and Bill are two stroke survivors who struggled with aphasia after their
strokes. Their lives were greatly affected, but with persistence and rehab,
they improved. Read their stories of survival and recovery.
|
 |
|
Support Group Resources
|
|

|
You requested materials for support group meetings and we listened. National Stroke Association is excited to announce the Afib-in-a-box program for support groups.
|
Our
first offering includes:
- A DVD with two presentations on Afib by Dr. David Willis
- A discussion guide for group activities
- Act FAST magnets and wallet cards
Quantities are limited—order today! Group leaders—call 1-800-STROKES (787-6537) or email supportgroups@stroke.org for a complimentary Afib-in-a-box program for your stroke support group.
This activity is sponsored by an educational grant from the Bristol-Myers Squibb/Pfizer, Inc. Partnership.
|
|
|

Where Caregivers Gather
Join Careliving℠
Community, where caregivers can connect, share, discuss and support
each other.
|
|



|
|
As a valued supporter of National Stroke Association, you will receive Brain Alert monthly to keep you up to date on stroke news and information.

|
|
Corporate Alliance
Board Members
Chairman level Allergan, Inc. • Boehringer Ingelheim Pharmaceuticals, Inc. • Genentech, Inc.
Executive level Bristol-Myers Squibb Company/Pfizer Inc. Partnership • Medtronic, Inc.
Director level Acorda Therapeutics • Allsup, Inc. • Avanir Pharmaceuticals • Janssen Pharmaceuticals, Inc. • Lundbeck • Patterson Medical
|
|